Pricing Log in Create free account

GH Research PLC (GHRS) vs Omeros Corporation (OMER)

GH Research PLC and Omeros Corporation are both Biotechnology companies. GH Research PLC and Omeros Corporation are of similar size ($1.4B and $1.3B). GH Research PLC has negative trailing earnings, so its P/E is not meaningful; Omeros Corporation trades at 9.5×. Omeros Corporation has the higher net margin (128.4% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Omeros Corporation leads on 7 and GH Research PLC on 5.

Valuation

Metric GHRS OMER Biotechnology median
P/E n/m 9.47 8.50
P/S n/m 12.02 9.71
P/B 3.36 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 11.83 9.21
Earnings yield (5.51%) 10.56% (33.15%)
Free cash flow yield (4.29%) (5.88%) (25.50%)

Profitability

Metric GHRS OMER Biotechnology median
Gross margin 0.00% 37.57% 65.16%
Operating margin 0.00% (74.88%) 0.00%
Net margin 0.00% 128.36% 0.00%
Free cash flow margin 0.00% (70.69%) 0.00%
Return on equity (18.79%) (89.15%) (56.36%)
Return on assets (18.16%) 51.22% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GHRS OMER Biotechnology median
Revenue growth (TTM) — 36.32% 6.02%
EPS growth (last fiscal year) (5.33%) 98.15% 30.26%
Revenue growth, 5-year CAGR — 40.44% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GHRS OMER Biotechnology median
Debt to equity 0.00 (1.89) 0.00
Current ratio 28.70 1.95 4.72
Net debt to EBITDA 4.65 (0.30) 0.96

Dividend

Metric GHRS OMER Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GHRS OMER Biotechnology median
Market cap 1.29b 1.36b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack